To ensure clarity, the focus of this discussion is primarily on autism and its association with folate receptor autoantibodies, while acknowledging that other neurological disorders, such as epilepsy and Parkinsons disease, may have related metabolic issues but are not necessarily linked directly to folate autoimmunity
p53s potential as a tumor suppressor is well-documented, primarily functioning to stop the proliferation of cells that have suffered DNA damage
As a core energy and biosynthetic substrate for tumor cells, Gln metabolic reprogramming has emerged as a research hotspot in tumor metabolism in recent years
What the Research Shows The majority of BPC-157 research is preclinical (animal studies)
Marote AFG, Teixeira B, Mendes-Pinheiro AJ, Salgado